More optic relief
October 24th, 2026Takeaways from this week in optometry: October 16-23This week's top stories include breaking FDA approvals, insights on AI-assisted front desk management, and more. Read more
October 22nd, 2026Brepocitinib for noninfectious uveitis meets all phase 3 trial end pointsCLARITY program data show significantly longer time to treatment failure and higher rates of steroid-free quiescence vs placebo.Read more
October 19th, 2026FDA approves Brytly eye drops for ocular redness relief lasting up to 12 hoursAlcon's Brytly eye drops received FDA approval for OTC temporary relief of minor ocular redness.Read more
October 19th, 2026Missed AAOpt 2026? Here are the highlights by specialtyFrom dry eye to GLP-1s, this year's conference brought a variety of insights from key experts in optometry. Read more